GLP-1s and Period Changes: What Is Known About Your Cycle on Semaglutide or Tirzepatide

The GLP-1 medications Pepti prescribes:

Prices are "from" prices and all-in, covering medication, physician review, refill management and shipping. Compounded medications are not FDA approved. The label information on this page comes from the approved manufactured products, which contain the same molecules.

The side-effect tables on the approved semaglutide and tirzepatide labels, as summarized in Pepti's references, are dominated by gastrointestinal effects: nausea, diarrhea, vomiting, constipation and abdominal pain, along with headache, fatigue, dizziness and hair loss. Menstrual changes are not among them. That is an absence in Pepti's sources, not proof that a GLP-1 never affects anyone's cycle, and this page claims neither.

The animal reproduction studies on the labels do record cycle effects in rats. In the semaglutide fertility study, estrus-cycle length increased at all dose levels in females, with a small reduction in corpora lutea. In the tirzepatide study, female rats had prolonged diestrus and fewer corpora lutea at all dose levels. Both labels attribute these to the drugs' effects on food intake and body weight rather than a direct hormonal action, and rat cycles are not human periods.

Reproduction runs on a pulse generator in the hypothalamus that drives the pituitary to release the hormones that mature a follicle and trigger ovulation. Body weight and metabolic health feed into that system. Obesity and insulin resistance are associated with reduced fertility, and in PCOS, ovulation is often irregular or absent. Substantial weight loss can restore ovulation, and a regular cycle follows ovulation.

The 2015 lifestyle trial

A randomized study in the Journal of Clinical Endocrinology and Metabolism in 2015 assigned 149 women with infertility due to PCOS and a body-mass index between 27 and 42 to sixteen weeks of continuous oral contraceptive pills, a lifestyle weight-loss program, or both, before standardized ovulation induction. Cumulative ovulation rates were 46% with the pill alone, 60% with lifestyle and 67% combined, a statistically significant difference favoring weight loss. Live birth rates were numerically higher in the weight-loss arms, but that difference did not reach significance.

The 2025 semaglutide trial

A randomized, controlled, open-label trial in Reproductive Biology and Endocrinology in 2025 assigned 100 women with overweight or obesity and PCOS to sixteen weeks of metformin alone or metformin plus once-weekly semaglutide, after which all continued on metformin alone and were followed to week 40. The semaglutide group lost more weight, had greater reductions in testosterone and inflammatory markers, had higher rates of menstrual cycle recovery, and had a higher natural pregnancy rate over follow-up, 35% against 15%. Eighty of the 100 completed the study.

A single, modestly sized, open-label trial from one center is not grounds to call semaglutide a treatment for irregular periods or PCOS. It is direct human evidence that cycles can change on treatment, and that the change can come with more conceptions, not fewer.

If you might be pregnant

Contact your physician the same day. For the GLP-1 medications, the approved labeling for the weight-reduction population says they are discontinued when a pregnancy is recognized, and both approved products have pregnancy exposure registries your physician can tell you about. The wider guidance is in can you take peptides while pregnant.

Other things a cycle change can point to

Menstrual blood loss is one reason iron deficiency is common in women, and iron deficiency causes fatigue, hair shedding and low mood that are easy to blame on a medication. Hair loss on semaglutide was reported in 3.3% against 1% on placebo, almost entirely in women, and the label attributes it to weight reduction. If you notice heavier periods along with tiredness or shedding, tell your care team so the whole picture is looked at. More is in peptides for women.

This is the practical point most likely to matter if your cycle changes.

Tirzepatide and the pill

The approved tirzepatide label states that it may reduce the efficacy of oral hormonal contraceptives because of delayed gastric emptying, that the delay is largest after the first dose and diminishes over time, and that people using oral hormonal contraceptives should switch to a non-oral method, or add a barrier method, for four weeks after starting and for four weeks after each dose increase. Hormonal contraceptives not taken by mouth are not expected to be affected.

Semaglutide and the pill

The drug interactions section of the approved semaglutide label reports no clinically significant differences in the pharmacokinetics of ethinyl estradiol or levonorgestrel when given alongside semaglutide. That is a real difference between the two molecules.

Ask your physician what they recommend for you specifically, and for how long. The full detail is in do peptides affect fertility.

There is no study in Pepti's references that looked at period changes as a side effect of semaglutide or tirzepatide in the general population. The evidence that exists is narrower: label tables that do not list menstrual effects, rat studies that attribute cycle changes to eating less, and trials in women with PCOS where weight loss, including on semaglutide, was followed by more ovulation, more cycle recovery and more pregnancies.

What follows from that is practical rather than reassuring or alarming. A change in your cycle on a GLP-1 is plausible, it may reflect ovulation returning, and the main thing it changes is your pregnancy risk. Report changes, keep contraception current, and do not assume any new or unusual bleeding is the medication.

Semaglutide and tirzepatide cannot be bought legitimately without a prescription. Products sold "for research use only" have no accountable pharmacy behind their identity, purity, sterility or concentration. The prescription route:

1. Complete a free online intake covering your history, medications and what you want help with, including your contraception and any plans for pregnancy.
2. A physician licensed in your state reviews it, usually within 24 hours.
3. If it is appropriate, a PCAB-accredited, FDA-registered US 503A compounding pharmacy prepares it to that prescription. Lot test results are published at /quality/lab-results.
4. It ships refrigerated with ice packs, with sterile syringes and alcohol prep pads, and your directions printed on the vial.
5. Your care team stays reachable for side effects and questions. Refills run every 28 days, one vial per fill.

Pepti is cash-pay and does not bill insurance. Bloodwork is not required for any Pepti treatment. If your physician wants labs for your care, they'll ask through your account. The step-by-step pages are how to get semaglutide prescribed online and how to get tirzepatide prescribed online.